RUN FROM THIS FAST ?
"Possible Upcoming Catalysts"
OR
"Why I am not buying this stock"
Lacking a partner this company may need a LOT OF MONEY for phase 3 testing and general operations. This company is most likely more than 12 months away from any new commercial product offering and income..
1- Stock will set a new low of 0.152 between now and market close Friday Sept 1
2- Reverse split 1 for 25 could be announced Friday Sept 1 AH effective Monday Sept 4 PM.
3- Stock may stabilize Monday the 4'th at 4 dollars (16 cents pre split).
4- Within 10 days Rosacea topline data may be announced resulting in stock climbing to record high of 8 dollars (actually only 32 cents pre split)
5- A few days later 25 million dollar offering may be announced priced at 7 dollars a share, stock will recede to 7 dollars, higher than post split opening weeks before but only 28 cents pre split.
SIGNS
Stock was increased from 90k to 450k shares by board in 2017, that authorization DOES NOT REVERSE SPLIT. That authorization STANDS in the wings for future sales and dilution of the retail shares.
Why offer 20 to 25 million at 15 to 30 cents and use up all your authorized stock inventory when you can reverse split and get the same amount of cash using A LOT LESS STOCK INVENTORY and also MAKE YOUR COMPANY listing compliant.
All signs may point to r/s, news release, major offering, dilution. The recent highly discounted tiny offering that crashed the stock to hi 20's is more evidence of the future.
Those entered at 50 cents pre split would need to wait for 12.50 stock price to break even.
A r/s almost ensures that any dream of major returns are dashed and replaced with hopes to get out even or with less loss at some future date.
AI
